BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$151M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$126M |
| 3 |
Alibaba
BABA
|
+$92.6M |
| 4 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$71M |
| 5 |
Lam Research
LRCX
|
+$54.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$1.15B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Apple
AAPL
|
+$837M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$723M |
| 5 |
Microsoft
MSFT
|
+$603M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.13% |
| 2 | Financials | 5.89% |
| 3 | Healthcare | 5.09% |
| 4 | Consumer Discretionary | 5% |
| 5 | Communication Services | 3.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
First Bancorp
FBNC
$2.74B
| $43K | ﹤0.01% |
1,316
+328
| +33% | +$12.2K |
|
|
IMPV
2702
DELISTED
Imperva, Inc.
IMPV
| $42.8K | ﹤0.01% |
769
-1,184
| -61% | -$64.3K |
|
2703
Greif
GEF
$4.97B
| $42.7K | ﹤0.01% |
1,150
-4,786
| -81% | -$224K |
|
2704
Marcus & Millichap
MMI
$1.2B
| $42.5K | ﹤0.01% |
1,237
-1,018
| -45% | -$34.9K |
|
2705
eHealth
EHTH
$39.1M
| $42.5K | ﹤0.01% |
1,105
+482
| +77% | +$16.2K |
|
|
VIVO
2706
DELISTED
Meridian Bioscience Inc
VIVO
| $42.2K | ﹤0.01% |
2,430
-89
| -4% | -$1.52K |
|
2707
Home BancShares
HOMB
$6.28B
| $42.1K | ﹤0.01% |
2,578
-13,994
| -84% | -$266K |
|
|
FOLD
2708
DELISTED
Amicus Therapeutics
FOLD
| $42.1K | ﹤0.01% |
4,392
-6,443
| -59% | -$70.8K |
|
2709
WSFS Financial
WSFS
$4.17B
| $42K | ﹤0.01% |
1,107
+108
| +11% | +$4.55K |
|
|
CTRL
2710
DELISTED
Control4 Corporation
CTRL
| $41.8K | ﹤0.01% |
2,376
-160
| -6% | -$3.79K |
|
2711
Resources Connection
RGP
$145M
| $41.7K | ﹤0.01% |
2,937
+1,264
| +76% | +$20.5K |
|
2712
Lithia Motors
LAD
$8.3B
| $41.5K | ﹤0.01% |
544
-1,232
| -69% | -$97.4K |
|
2713
Vishay Intertechnology
VSH
$5.38B
| $41.4K | ﹤0.01% |
2,298
-18,148
| -89% | -$342K |
|
2714
Pacira BioSciences
PCRX
$917M
| $41.3K | ﹤0.01% |
961
-1,323
| -58% | -$61.8K |
|
2715
PetMed Express
PETS
$38.9M
| $41.3K | ﹤0.01% |
1,774
-3,900
| -69% | -$104K |
|
2716
BOK Financial
BOKF
$8.88B
| $41K | ﹤0.01% |
559
-5,185
| -90% | -$439K |
|
2717
Harmonic Inc
HLIT
$1.51B
| $40.9K | ﹤0.01% |
8,674
+5,957
| +219% | +$32.5K |
|
|
RDC
2718
DELISTED
Rowan Companies Plc
RDC
| $40.9K | ﹤0.01% |
4,871
-11,073
| -69% | -$163K |
|
2719
QuidelOrtho
QDEL
$981M
| $40.9K | ﹤0.01% |
837
-994
| -54% | -$59.3K |
|
2720
Eagle Bancorp
EGBN
$878M
| $40.7K | ﹤0.01% |
836
-1,280
| -60% | -$65.1K |
|
|
SUM
2721
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $40.6K | ﹤0.01% |
3,331
-3,133
| -48% | -$43.3K |
|
2722
Varex Imaging
VREX
$779M
| $40.6K | ﹤0.01% |
1,714
-565
| -25% | -$14.3K |
|
|
MAGN
2723
Magnera Corp
MAGN
$444M
| $40.6K | ﹤0.01% |
320
+121
| +61% | +$23.2K |
|
2724
Fox Factory Holding Corp
FOXF
$883M
| $40.5K | ﹤0.01% |
688
-897
| -57% | -$55.9K |
|
2725
Inogen
INGN
$153M
| $40.5K | ﹤0.01% |
326
-1,512
| -82% | -$249K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2018 Portfolio in Review
As of Q4 2018, BNP Paribas Financial Markets held 4,572 positions worth $42.3B, down 38% from $67.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BNP Paribas Financial Markets withdrew a net $18.9B in Q4 2018, closing 248 positions and reducing 2,296 holdings. Its most notable exit was Aetna Inc, an estimated $141M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.1% of assets, down from 9.7% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in HUTCHMED worth $8.84M.
- BNP Paribas Financial Markets's largest Q4 2018 buy was HUTCHMED: 382,749 shares worth $8.84M.
- BNP Paribas Financial Markets added most to Celgene Corp in Q4 2018, an estimated $151M increase.
- BNP Paribas Financial Markets's biggest Q4 2018 reduction was Alphabet (Google) Class C, cutting an estimated $1.15B.
- BNP Paribas Financial Markets fully exited Aetna Inc in Q4 2018, selling an estimated $141M.
- BNP Paribas Financial Markets's ten largest holdings make up 19% of its $42.3B portfolio in Q4 2018.
- BNP Paribas Financial Markets opened 126 new positions and closed 248 in Q4 2018.
- BNP Paribas Financial Markets's portfolio value fell 38% quarter-over-quarter to $42.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2018, filed 12 Feb 2019.